Abiopharma

🔍 Rubenstein Robert (Executive)

Company: HYPERION DEFI, INC. (HYPD)

Report Date: 2026-01-12

Detailed Transactions and Holdings:

• Acquired 75,000 shares of Common Stock, par value $0.0001 (Direct)
  Date: 2026-01-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 75,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents restricted stock units ("RSUs") that vest as follows: (1) 37,500 RSUs shall vest on January 12, 2027 and (2) 37,500 RSUs shall vest in equal installments of 9,375 RSUs beginning three months after January 12, 2027 and continuing every three months thereafter until fully vested, subject to the Reporting Person's continued employment with the Company through each such vesting date.